ATGENGLOBAL
Dead / Abandoned — Abandoned — failure to respond (as of 24 Sept 2019)
What this means for you
This application is over — abandoned 27 Aug 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88191008
- Mark type
- Stylized text
- Filed
- 12 Nov 2018
- Abandoned
- 27 Aug 2019
- Attorney of record
- MARGARET C. MCHUGH
Goods and services
- Class 001 — Chemicals: Proteins in raw material form for scientific and medical research; Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for use by others in manufacturing pharmaceutical and veterinary preparations; proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens and antibodies for scientific and research purposes; diagnostic kits for clinical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status diagnostic kits for medical laboratory use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for medical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic kits for clinical research use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA in disease diagnosis screening, and immune status; diagnostic preparations for clinical laboratory use and medical laboratory use; diagnostic preparations for clinical research use other than for medical use; diagnostic reagents for clinical laboratory use, medical laboratory use, medical research use and clinical research use
- Class 005 — Pharmaceuticals: Proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones for veterinary or medical purposes: hormones; diagnostic kits for medical diagnostic use, namely, kits consisting primarily of monoclonal antibodies and/or recombinant proteins, RNA, DNA for use in disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic activators in the nature of proteins for use in diagnostic kits for disease diagnosis, screening, monitoring, prognosis, and immune status; diagnostic preparations for medical diagnostic use; diagnostic reagents for medical diagnostic use
- Class 035 — Advertising and business services: Online retail store services featuring proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; online retail store services featuring vitro diagnostic devices and antibody detection kits
- Class 040 — Treatment of materials: Custom manufacture of proteins, neuroproteins, recombinant proteins, heat shock proteins, enzymes, ubiquitins, cancer related proteins, viral antigens, antibodies and hormones; Custom manufacture of in vitro diagnostic devices and antibody detection kits
- Class 042 — Scientific and technological services: medical research services; scientific research, namely, conducting clinical research trials; research and development of medicines based on protein and peptide therapeutic applications; medical diagnostic services; biological DNA cloning services; protein expression services in the field of biotechnology, namely, DNA gene cloning services, purification process development; laboratory services relating to the production of monoclonal antibodies; medical and scientific research services, namely, monoclonal antibody development, generation and screening and design related thereto
Owner
- ATGen Co., Ltd., Gyeonggi-do 463-400, KR
Prosecution history
- 24 Sept 2019 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 24 Sept 2019 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 26 Feb 2019 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 26 Feb 2019 — NON-FINAL ACTION E-MAILED
- 26 Feb 2019 — NON-FINAL ACTION WRITTEN
- 14 Feb 2019 — ASSIGNED TO EXAMINER
- 30 Nov 2018 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 15 Nov 2018 — NEW APPLICATION ENTERED